Autopsy report · NCT00554112

Regulation of B-Cell Function & Glucose Tolerance in Older People

“PI left the VA, per Central Office”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 9 months before it stopped.
• 90 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

US Department of Veterans Affairs

Sponsor type

US federal agency

Conditions

Aging; Glucose Intolerance

Interventions

Exercise

Participants

90 (planned, not actual)

Trials that died the same way

• Analgesic Efficacy of Testosterone Replacement in Hypogonadal Opioid-treated Chronic Pain Patients: A Pilot Study.
  “The original PI (David Siegel) Left the VA” (66% match in meaning)
• Adjunct Dexmedetomidine (Precedex®) Therapy Impact on Sedative and Analgesic Requirement
  “PI resigned.” (65% match in meaning)
• Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease
  “PI left the institution” (64% match in meaning)
• Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies
  “Former PI Left the Institution” (63% match in meaning)
• Longitudinal Analysis of Gait Variability to Predict Falls in Parkinson's Disease
  “PI left the institution and the US” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.